期刊文献+

对氧磷脂酶家族与2型糖尿病及血管并发症关系的研究 被引量:1

Association of variation of paraoxonase activity with diabetic vessel complications
下载PDF
导出
摘要 目的研究对氧磷脂酶-1(PON1)活性与2型糖尿病大中血管及微血管病变的关系及丙二醛(MDA)水平的变化。方法用紫外分光光度法测定正常对照组(NC),2型糖尿病组(DM),2型糖尿病血管并发症组血清PON1活性及MDA水平。结果PON1活性在各组分别为:正常对照组(163.84±62.98)kU/L,2型糖尿病组(118.87±30.38)kU/L,并发冠心病组(DMCHD)(95.83±23.76)kU/L,并发脑梗死组(DMCI)(94.46±24.36)kU/L,并发肾病组(DN)(106.93±20.21)kU/L,并发肾病视网膜病变组(DNDR)(100.13±24.42)kU/L(P<0.01);MDA水平在各组分别为:NC组(3.48±0.50)μmol/L,DM组(4.02±0.75)μmol/L,DMCHD组(4.67±0.74)μmol/L,DMCI组(4.55±1.39)μmol/L,DN组(3.95±0.62)μmol/L,DNDR组(4.30±0.43)μmol/L(P<0.01)。结论与正常对照组相比,2型糖尿病组PON1活性降低,MDA水平升高;血管并发症组PON1活性更低而MDA水平进一步升高,说明2型糖尿病的脂质过氧化增加,血清PON1活性下降,并参与2型糖尿病及血管并发症的发生。 Objective To investigate the association of variation of paraoxonase (PON1) activity with the diabetic vascular complications. Methods PON1 activity was determined with spectrophotography in type two diabetes mellitus(DM) patients,DM with vascular complications patients and normal control subjects. Results PON1 activity was(163.84±62.98) kU/L in normal control group(NC), in DM group was (118.87 ± 30.38) kU/L, in DM with coronary heart disease group(DMCHD) was (95.83± 23.76) kU/L, in diabetes mellitus with cerebral infarction group was (94.46 ± 24.36) kU/L, in diabetic nephropathy(DN) group was (106.93 ± 20.21) kU/L, and in diabetic nephropathy diabetic retinopathy(DNDR) group was (100.13 ± 24.42) kU/L( P 〈0.01). MDA concentration was (3.48±0.50) μmol/L in NC group, in DM group was (4.02±0.75) μmol/L, in DMCHD group was (4.67±0.74) μmol/L, in DMCI group was (4.55±1.39) μmol/L, in DN group was (3.95±0.62) μmol/L, and in DNDR group was (4.30±0. 43) μmol/L( P 〈0.01). Conclusion PON1 activity of DM patients and DM with vascular complication patients was significantly lower than that of control subjects,while MDA level increased. Further more, PON1 activity of DM with vascular complications was lower than that of DM patients. It signifies that decreased serum PON1 activity promoted the development of diabetic vascular complications.
出处 《临床荟萃》 CAS 北大核心 2006年第7期465-467,共3页 Clinical Focus
基金 河南省科技攻关基金资助项目(0424410098)
关键词 糖尿病 2型 糖尿病发症 磷脂酶类 脂质过氧化作用 diabetes mellitus,type 2 diabetes complications phospholipases lipid peroxidation
  • 相关文献

参考文献8

  • 1Baynes JW.Role of oxidative stress in development of complications in diabetes[J].Diabetes,1991,40(12):405-412.
  • 2Wolff SP,Jiang ZY,Hunt JV.Protein glycation and oxidative stress in diabetes mellitus and aging[J].Free Radic Biol Med,1991,10(12):339-352.
  • 3杜玮南,温进坤,韩梅.人血清对氧磷酶活性测定方法的建立及临床初步应用[J].河北医科大学学报,1999,20(3):134-136. 被引量:22
  • 4Shih DM,Gu L,Xia YR,et al.Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis[J].Nature,1998,394(6690):284-287.
  • 5Avirma M,Mira R,Charles L,et al.Paraoxonase inhibits highdensity lipoprotein oxidation and preserves its functions a possible peroxidative role for paraoxonase[J].J Clin Inves,1998,101(20):1581-1590.
  • 6Aviram M,Hardak E,Vaya J,et al.Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions:PON1 esterase and peroxidase-like activities[J].Circulation,2000,101(21):2510-2517.
  • 7Navab M,Hama SY,Anantharamaiah GM,et al.Normal high density lipoprotein inhibits three steps in the gormation of mildly oxidized low density lipoprotein:steps 2 and 3[J].J Lipid Res,2000,41(9):1495-1508.
  • 8Orit R,Diana MS,Aviram M.Human serum paraoconase 1 decreases macrophage cholesterol biosynthesis possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation[J].Arterioscler Thromb Vasc Biol,2003,23(12):461-467.

共引文献21

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部